These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
293 related items for PubMed ID: 7639340
1. Chemical and immunological heterogeneity of fibrillar amyloid in plaques of Alzheimer's disease and Down's syndrome brains revealed by confocal microscopy. Schmidt ML, Robinson KA, Lee VM, Trojanowski JQ. Am J Pathol; 1995 Aug; 147(2):503-15. PubMed ID: 7639340 [Abstract] [Full Text] [Related]
2. A study of the morphology and distribution of amyloid beta protein immunoreactive plaque and related lesions in the brains of Alzheimer's disease and adult Down's syndrome. Ikeda S, Allsop D, Glenner GG. Prog Clin Biol Res; 1989 Aug; 317():313-23. PubMed ID: 2532370 [Abstract] [Full Text] [Related]
3. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation. Lemere CA, Blusztajn JK, Yamaguchi H, Wisniewski T, Saido TC, Selkoe DJ. Neurobiol Dis; 1996 Feb; 3(1):16-32. PubMed ID: 9173910 [Abstract] [Full Text] [Related]
4. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease. Liu K, Solano I, Mann D, Lemere C, Mercken M, Trojanowski JQ, Lee VM. Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398 [Abstract] [Full Text] [Related]
5. Plaque-associated neuronal proteins: a recurrent motif in neuritic amyloid deposits throughout diverse cortical areas of the Alzheimer's disease brain. Schmidt ML, DiDario AG, Otvos L, Hoshi N, Kant JA, Lee VM, Trojanowski JQ. Exp Neurol; 1994 Dec; 130(2):311-22. PubMed ID: 7867760 [Abstract] [Full Text] [Related]
6. The presence of isoaspartic acid in beta-amyloid plaques indicates plaque age. Fonseca MI, Head E, Velazquez P, Cotman CW, Tenner AJ. Exp Neurol; 1999 Jun; 157(2):277-88. PubMed ID: 10364440 [Abstract] [Full Text] [Related]
7. Apolipoprotein D is a component of compact but not diffuse amyloid-beta plaques in Alzheimer's disease temporal cortex. Desai PP, Ikonomovic MD, Abrahamson EE, Hamilton RL, Isanski BA, Hope CE, Klunk WE, DeKosky ST, Kamboh MI. Neurobiol Dis; 2005 Nov; 20(2):574-82. PubMed ID: 15916898 [Abstract] [Full Text] [Related]
8. Morphology and distribution of plaque and related deposits in the brains of Alzheimer's disease and control cases. An immunohistochemical study using amyloid beta-protein antibody. Ikeda S, Allsop D, Glenner GG. Lab Invest; 1989 Jan; 60(1):113-22. PubMed ID: 2642985 [Abstract] [Full Text] [Related]
9. Evidence of amyloid beta-protein immunoreactive early plaque lesions in Down's syndrome brains. Ikeda S, Yanagisawa N, Allsop D, Glenner GG. Lab Invest; 1989 Jul; 61(1):133-7. PubMed ID: 2473275 [Abstract] [Full Text] [Related]
10. Full-length amyloid-beta (1-42(43)) and amino-terminally modified and truncated amyloid-beta 42(43) deposit in diffuse plaques. Iwatsubo T, Saido TC, Mann DM, Lee VM, Trojanowski JQ. Am J Pathol; 1996 Dec; 149(6):1823-30. PubMed ID: 8952519 [Abstract] [Full Text] [Related]
11. Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease. Joachim CL, Mori H, Selkoe DJ. Nature; 1989 Sep 21; 341(6239):226-30. PubMed ID: 2528696 [Abstract] [Full Text] [Related]
12. Is the "preamyloid" of diffuse plaques in Alzheimer's disease really nonfibrillar? Davies CA, Mann DM. Am J Pathol; 1993 Dec 21; 143(6):1594-605. PubMed ID: 8256851 [Abstract] [Full Text] [Related]
13. Molecular dating of senile plaques in the brains of individuals with Down syndrome and in aged dogs. Azizeh BY, Head E, Ibrahim MA, Torp R, Tenner AJ, Kim RC, Lott IT, Cotman CW. Exp Neurol; 2000 May 21; 163(1):111-22. PubMed ID: 10785449 [Abstract] [Full Text] [Related]
14. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain. Güntert A, Döbeli H, Bohrmann B. Neuroscience; 2006 Dec 01; 143(2):461-75. PubMed ID: 17008022 [Abstract] [Full Text] [Related]
15. Amino-terminal modification and tyrosine phosphorylation of [corrected] carboxy-terminal fragments of the amyloid precursor protein in Alzheimer's disease and Down's syndrome brain. Russo C, Salis S, Dolcini V, Venezia V, Song XH, Teller JK, Schettini G. Neurobiol Dis; 2001 Feb 01; 8(1):173-80. PubMed ID: 11162251 [Abstract] [Full Text] [Related]
16. Selective binding of soluble Abeta1-40 and Abeta1-42 to a subset of senile plaques. Prior R, D'Urso D, Frank R, Prikulis I, Cleven S, Ihl R, Pavlakovic G. Am J Pathol; 1996 Jun 01; 148(6):1749-56. PubMed ID: 8669461 [Abstract] [Full Text] [Related]
17. Amyloid beta protein and the basis for Alzheimer's disease. Glenner GG. Prog Clin Biol Res; 1989 Jun 01; 317():857-68. PubMed ID: 2690126 [Abstract] [Full Text] [Related]
18. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome. Snow AD, Mar H, Nochlin D, Sekiguchi RT, Kimata K, Koike Y, Wight TN. Am J Pathol; 1990 Nov 01; 137(5):1253-70. PubMed ID: 2146882 [Abstract] [Full Text] [Related]
19. Cerebral extracellular preamyloid deposits in Alzheimer's disease, Down syndrome and nondemented elderly individuals. Tagliavini F, Giaccone G, Linoli G, Frangione B, Bugiani O. Prog Clin Biol Res; 1989 Nov 01; 317():1001-5. PubMed ID: 2532368 [Abstract] [Full Text] [Related]
20. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemens J, Donaldson T, Gillespie F. Nature; 1995 Feb 09; 373(6514):523-7. PubMed ID: 7845465 [Abstract] [Full Text] [Related] Page: [Next] [New Search]